Showing results (211-220 of 290) with videos related to

Sort By:
Pageof 29
The Lancet. Oncology|March 29, 2012
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trialVincent A Miller, Vera Hirsh, Jacques Cadranel, et al.
The Journal of Molecular Diagnostics : JMD|August 25, 2019
A Novel Next-Generation Sequencing Approach to Detecting Microsatellite Instability and Pan-Tumor Characterization of 1000 Microsatellite Instability-High Cases in 67,000 Patient SamplesSally E Trabucco, Kyle Gowen, Sophia L Maund, et al.
European Urology Focus|June 1, 2019
Genomic Features of Metastatic Testicular Sex Cord Stromal TumorsAndrea Necchi, Gennady Bratslavsky, Oleg Shapiro, et al.
JCO Precision Oncology|June 21, 2019
Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate TumorsJon H Chung, Ninad Dewal, Ethan Sokol, et al.
Urologic Oncology|March 29, 2021
Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinomaGennady Bratslavsky, Stephanie Gleicher, Joseph M Jacob, et al.
The Oncologist|February 18, 2017
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase FusionsPierre Vanden Borre, Alexa B Schrock, Peter M Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2018
Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or AnusAlexa B Schrock, Dean Pavlick, Samuel J Klempner, et al.
The Oncologist|April 18, 2015
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapiesSiraj M Ali, Eric M Sanford, Samuel J Klempner, et al.
European Urology|June 9, 2017
Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic ProfilingSumanta K Pal, Siraj M Ali, Evgeny Yakirevich, et al.
Nature Medicine|April 24, 2019
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT studyJason K Sicklick, Shumei Kato, Ryosuke Okamura, et al.
Pageof 29